Stock Comparison
ELAN vs TAK
Elanco Animal Health and Takeda Pharmaceutical Co Ltd ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$11.15B
$55.20B
P/E (TTM)
—
—
Forward P/E
20.3
10.6
Price/Sales
2.2
0.0
Price/Book
1.7
1.2
EV/EBITDA
18.7
22.6
Dividend Yield
—
1.85%
Profitability
Net Margin
-4.95%
4.25%
Operating Margin
8.95%
10.89%
Return on Equity
-2.98%
-2.26%
Return on Assets
1.56%
2.69%
Growth (YoY)
Revenue Growth
10.20%
10.20%
Earnings Growth
440.50%
-9.80%
Price & Risk
Beta
1.7
0.1
52-Week High
$26.84
$18.80
52-Week Low
$17.35
$13.23
Analyst Target
$31.21
$21.59
Compare ELAN and TAK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.